InxMed
InxMed is a biotech company. It has raised $65.0M across 2 rounds, most recently a $15.0M Series B in May 2022.
- Website
- en.inxmed.com
- Total Funding
- $65.0M
- Last Round
- $15.0M Series BMay 2022
- Rounds
- 2
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 2 funding rounds and 3 investors for this company. The full record is or through the API.
About
It has raised $65.0M in total across 2 rounds, most recently a $15.0M Series B round in May 2022. Investors include China Growth Capital, SDIC Fund Management and CD Capital.
Funding History
May 2022
Sign up to see all 2 events
Funding: Series B. Amounts, valuations, and investors where available.
Investors
Similar Companies
Altos Labs combines academic science and industry development to create medicines that restore ce...
BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/inxmed"><img src="https://indexed.vc/api/badge/company/inxmed" alt="InxMed on Indexed.vc" width="260" height="76" /></a>